KD Logo

DermTech Inc (DMTK) receives an Outperform rating from Oppenheimer

DermTech Inc’s recently made public that its Chief Financial Officer Sun Kevin M unloaded Company’s shares for reported $648.0 on Dec 11 ’23. In the deal valued at $1.45 per share,447 shares were sold. As a result of this transaction, Sun Kevin M now holds 277,499 shares worth roughly $0.17 million.

Then, Ibarra Claudia sold 331 shares, generating $480 in total proceeds. Upon selling the shares at $1.45, the Chief Operating Officer now owns 193,547 shares.

Before that, Ibarra Claudia sold 2,607 shares. DermTech Inc shares valued at $3,676 were divested by the Chief Operating Officer at a price of $1.41 per share. As a result of the transaction, Ibarra Claudia now holds 193,878 shares, worth roughly $0.12 million.

A number of analysts have revised their coverage, including BTIG Research’s analysts, who remained covering the stock and in mid June has reiterated a ‘”a Buy”‘ rating for it. Stephens began covering DMTK with “an Overweight” recommendation on January 07, 2022.

Price Performance Review of DMTK

On Tuesday, DermTech Inc [NASDAQ:DMTK] saw its stock fall -0.21% to $0.63. Over the last five days, the stock has gained 0.98%. DermTech Inc shares have fallen nearly -64.23% since the year began. Nevertheless, the stocks have fallen -72.90% over the past one year. While a 52-week high of $3.90 was reached on 01/02/24, a 52-week low of $0.57 was recorded on 04/30/24. SMA at 50 days reached $0.7051, while 200 days put it at $1.4512. A total of 0.31 million shares were traded, compared to the trading of 0.15 million shares in the previous session.

Levels Of Support And Resistance For DMTK Stock

The 24-hour chart illustrates a support level at 0.5943, which if violated will result in even more drops to 0.5627. On the upside, there is a resistance level at 0.6663. A further resistance level may holdings at 0.7067. The Relative Strength Index (RSI) on the 14-day chart is 44.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0137, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 54.24%. Stochastics %K at 46.98% indicates the stock is a holding.

The most recent change occurred on May 03, 2021 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $53 price target.

Most Popular

[the_ad id="945"]